Correlation Between FrontView REIT, and Medipharm Labs

Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FrontView REIT, and Medipharm Labs Corp, you can compare the effects of market volatilities on FrontView REIT, and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Medipharm Labs.

Diversification Opportunities for FrontView REIT, and Medipharm Labs

0.11

Correlation Coefficient

FrontView REIT,  Medipharm Labs

Average diversification

The 3 months correlation between FrontView and Medipharm is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Medipharm Labs go up and down completely randomly.

Pair Corralation between FrontView REIT, and Medipharm Labs

Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the Medipharm Labs. But the stock apears to be less risky and, when comparing its historical volatility, FrontView REIT, is 3.1 times less risky than Medipharm Labs. The stock trades about -0.02 of its potential returns per unit of risk. The Medipharm Labs Corp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  5.00  in Medipharm Labs Corp on September 25, 2024 and sell it today you would lose (0.78) from holding Medipharm Labs Corp or give up 15.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	11.9%
Values	Daily Returns

FrontView REIT,  vs.  Medipharm Labs Corp

FrontView REIT,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Medipharm Labs Corp

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with FrontView REIT, and Medipharm Labs

The main advantage of trading using opposite FrontView REIT, and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.

The idea behind FrontView REIT, and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.